Modulation of CD40L antigen expression in Jurkat cells: Involvement of protein kinase C activity

Folia Histochemica et Cytobiologica

Volumn 41, Issue 4, 2003, Pages 233-235

  Lisowska, Katarzyna ^a   Bryl, Ewa ^a   Soroczyńska, Monika ^a   Witkowski, Jacek M ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

CD40L antigen; Jurkat cells; Protein kinase C (PKC)

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CD40 LIGAND; CHELERYTHRINE; CYCLOSPORIN A; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASSAY; CELL CLONE; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ANTAGONISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; MONONUCLEAR CELL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0242467938     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, Van Kooten C, Liu YJ, Rousset F, Saeland S (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12: 881-922
2. Bridges AJ, Norback D, Fisch P, England D, Sondel P (1990) T helper-cell leukemia/lymphoma: Presentation as an acute immune-mediated illness. J Clin Immunol 10: 61-70
3. Grewel IS, Flavell RA (1996) The role of CD40 ligand in costimulation and T cell activation. Immunol Rev 153: 85-106
4. Hirai M, Gamou S, Kobayashi M, Shimizu N (1989) Lung cancer cells often express high level of protein kinase C activity. Jpn J Cancer Res 80: 204-208
5. Inghirami G, Lederman S, Yellin MJ, Chadburn A, Chess L, Knowles DM (1994) Phenotypic and functional characterization of T-BAM (CD40 ligand) T-cell non-Hodgkin's lymphoma. Blood 84: 866-872
6. Jarzabek K, Laudański P, Dziecioł J, Dabrowska M, Wolczyński S (2002) Protein kinase C involvement in proliferation and survival of breast cancer cells. Folia Histochem Cytobiol 40: 193-194.
7. Lee SK, Qing WG, Mar W, Luyengi L, Mehta RG, Kawanishi K, Fong HH, Beecher CW, Kinghorn AD, Pezzuto JM (1998) Angoline and chelerythrine, benzophenanthridine alkaloids that do not inhibit protein kinase C. J Biol Chem 273: 19829-33
8. Lichtenstein A, Taylor CR (1980) Serum immunoglobulin levels in patients with non-Hodgkin's lymphoma. Am J Clin Pathol 74: 12-17
9. + T cells. J Immunol 151: 2497-2510
10. Rzeski W, Paduch R, Klatka J, Kandefer-Szerszeń M, Stepulak A, Pozarowski P, Zdzisińska B (2002) Establishment and preliminary characterization of two cell lines derived from larynx carcinoma. Folia Histochem Cytobiol 40: 195-6
11. Siomboing X, Gressier B, Dine T, Brunet C, Luyckx M, Cazin M, Cazin J-C (2001) Investigation of the inhibitory effects of chelerythrine chloride on the translocation of the protein kinase C βI, βII, ζ in human neutrophils. Il Farmaco 56: 859-865.
12. Timuragaoglu A, Duman A, Ongut G, Saka O, Karadogan I (2000) The significance of autoantibodies in non-Hodgkin's lymphoma. Leuk Lymphoma 40: 119-122
13. Von Stebut E, Amon U, Herbert JM, Wolff HH (1994) Investigation with the selective PKC inhibitor chelerythrine on the human basophils. Agents Actions 41: 56-57